NASDAQ · PPH
VanEck Pharmaceutical ETF
$119.33+$2.41 (+2.06%)
VanEck Pharmaceutical ETF’s quoted price sits in the upper half of its reported 52-week range, 1.27% below the high.
Loading market information…
AMEX · GXUS · USD
Stock price, dividends
Quote as of Oct 30, 2026, 07:59 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Goldman Sachs MarketBeta Total International Equity ETF’s quoted price sits in the upper half of its reported 52-week range, 7.46% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Goldman Sachs MarketBeta Total International Equity ETF’s forward annual dividend is $1.95 per share, paid quarterly. The forward yield is 3.21% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
The Goldman Sachs MarketBeta Total International Equity ETF strives to achieve investment returns that closely mirror the performance of the Solactive GBS Global Markets ex United States Large & Mid Cap Index, prior to the subtraction of any applicable fees and expenses.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 12:42 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
$119.33+$2.41 (+2.06%)
VanEck Pharmaceutical ETF’s quoted price sits in the upper half of its reported 52-week range, 1.27% below the high.
$58.82-$0.76 (-1.28%)
JPMorgan U.S. Value Factor ETF’s quoted price sits in the upper half of its reported 52-week range, 3.0% below the high.
$246.64-$1.82 (-0.73%)
State Street SPDR S&P 1500 Value Tilt ETF’s quoted price sits in the upper half of its reported 52-week range, 1.73% below the high.
$78.52-$0.46 (-0.58%)
iShares Morningstar Small Cap Value ETF’s quoted price sits in the upper half of its reported 52-week range, 4.28% below the high.
$66.71-$0.57 (-0.84%)
Longview Advantage ETF’s quoted price sits in the upper half of its reported 52-week range, 2.11% below the high.
$64.86-$3.55 (-5.19%)
Sprott Gold Miners ETF’s quoted price sits in the lower half of its reported 52-week range, 32.79% below the high.
$21.56-$0.16 (-0.74%)
RPAR Risk Parity ETF’s quoted price sits in the lower half of its reported 52-week range, 8.99% below the high.
$101.00-$0.55 (-0.54%)
VictoryShares US 500 Volatility Wtd ETF’s quoted price sits in the upper half of its reported 52-week range, 2.05% below the high.
